(Q37990324)

26 August 2017

title

Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease (English)

1 reference

26 August 2017

1 reference

3

Thérèse Di Paolo

1 reference

26 August 2017

1

Mélanie Bourque

1 reference

26 August 2017

Dean E Dluzen

2

1 reference

26 August 2017

publication date

1 March 2012

1 reference

Frontiers in Neuroendocrinology

26 August 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

26 August 2017

volume

33

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

169-178

1 reference

Benzothiophene Selective Estrogen Receptor Modulators Provide Neuroprotection by a novel GPR30-dependent Mechanism

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Selective oestrogen receptor modulators decrease the inflammatory response of glial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Role of astroglia in the neuroplastic and neuroprotective actions of estradiol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Neuroprotective effects of estradiol in the adult rat hippocampus: Interaction with insulin-like growth factor-I signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Gender and the Parkinson's disease phenotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Neuroprotection by estrogen against MPP+-induced dopamine neuron death is mediated by ERalpha in primary cultures of mouse mesencephalon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Neuroprotective effect of genistein in 6-hydroxydopamine hemi-parkinsonian rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Neuroprotective actions of sex steroids in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Sex differences in methamphetamine toxicity in mice: effect on brain dopamine signaling pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Requirements of a brain selective estrogen: advances and remaining challenges for developing a NeuroSERM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Dendrite loss is a characteristic early indicator of toxin-induced neurodegeneration in rat midbrain slices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Insulin-like growth factor I receptors and estrogen receptors colocalize in female rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Synergistic interaction of estradiol and insulin-like growth factor-I in the activation of PI3K/Akt signaling in the adult rat hypothalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

MatInspector and beyond: promoter analysis based on transcription factor binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Selective estrogen receptor modulators decrease the production of interleukin-6 and interferon-gamma-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Mesostriatal and mesolimbic projections of midbrain neurons immunoreactive for estrogen receptor beta or androgen receptors in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Postmenopausal estrogen use affects risk for Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Differential protective properties of estradiol and tamoxifen against methamphetamine-induced nigrostriatal dopaminergic toxicity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Parkinson's disease: mechanisms and models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Signal transduction by the JNK group of MAP kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Membrane estrogen receptor-alpha interactions with metabotropic glutamate receptor 1a modulate female sexual receptivity in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Astrocyte-derived transforming growth factor-{beta} mediates the neuroprotective effects of 17{beta}-estradiol: involvement of nonclassical genomic signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

17 beta-Estradiol at a physiological dose acutely increases dopamine turnover in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Both estrogen and raloxifene protect against beta-amyloid-induced neurotoxicity in estrogen receptor alpha-transfected PC12 cells by activation of telomerase activity via Akt cascade.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERalpha in estradiol-mediated protection against delayed cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERα) phosphorylation signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Aromatase in the brain: not just for reproduction anymore.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Interactions of estradiol and insulin-like growth factor-I signalling in the nervous system: new advances.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Estrogen receptor α and G-protein coupled receptor 30 mediate the neuroprotective effects of 17β-estradiol in novel murine hippocampal cell models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Raloxifene exposure enhances brain activation during memory performance in healthy elderly males; its possible relevance to behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Membrane estrogen receptors activate the metabotropic glutamate receptors mGluR5 and mGluR3 to bidirectionally regulate CREB phosphorylation in female rat striatal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Gender differences in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Role of extracellular signal regulated kinases 1 and 2 in neuronal survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Chemical neuroanatomy of the basal ganglia--normal and in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Emerging roles of Wnts in the adult nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Rapid stimulation of the PI3-kinase/Akt signalling pathway in developing midbrain neurones by oestrogen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Direct interactions with G α i and G βγ mediate nongenomic signaling by estrogen receptor α .

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Membrane estrogen receptors stimulate intracellular calcium release and progesterone synthesis in hypothalamic astrocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

GSK3B polymorphisms alter transcription and splicing in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

A Wnt1 regulated Frizzled-1/β-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Glia as a turning point in the therapeutic strategy of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Acute administration of non-classical estrogen receptor agonists attenuates ischemia-induced hippocampal neuron loss in middle-aged female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Estrogen and tamoxifen reverse manganese-induced glutamate transporter impairment in astrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Estrogen and tamoxifen protect against Mn-induced toxicity in rat cortical primary cultures of neurons and astrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

G protein-coupled receptor 30: estrogen receptor or collaborator?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Protective effect of estrogen on apoptosis in a cell culture model of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Neurocytoprotective effects of the bioactive constituents of Pueraria thomsonii in 6-hydroxydopamine (6-OHDA)-treated nerve growth factor (NGF)-differentiated PC12 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Estrogen signaling multiple pathways to impact gene transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Expression and intracellular distribution of the G protein-coupled receptor 30 in rat hippocampal formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Immunolocalization of Estrogen Receptor β in the Mouse Brain: Comparison with Estrogen Receptor α

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Loss of aromatase cytochrome P450 function as a risk factor for Parkinson's disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Estrogen and SERM neuroprotection in animal models of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Role of estrogen receptors in neuroprotection by estradiol against MPTP toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Development of subtype-selective oestrogen receptor-based therapeutics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

GPR30 does not mediate estrogenic responses in reproductive organs in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

PKB and the mitochondria: AKTing on apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Estrogen receptor-alpha is associated with the plasma membrane of astrocytes and coupled to the MAP/Src-kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Nature of functional estrogen receptors at the plasma membrane.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/MPP-treated neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

The G-protein-coupled estrogen receptor GPER in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Distribution and localization patterns of estrogen receptor-beta and insulin-like growth factor-1 receptors in neurons and glial cells of the female rat substantia nigra: localization of ERbeta and IGF-1R in substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Trolox and 17beta-estradiol protect against amyloid beta-peptide neurotoxicity by a mechanism that involves modulation of the Wnt signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Risk of Parkinson disease in women: effect of reproductive characteristics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Rapid estrogen signaling in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

A transmembrane intracellular estrogen receptor mediates rapid cell signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Pregnancy in Parkinson's disease: case report and discussion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Gender differences and estrogen effects in parkin null mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Parkinson's disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Effect of a chronic treatment with 17β-estradiol on striatal dopamine neurotransmission and the Akt/GSK3 signaling pathway in the brain of ovariectomized monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Validity of spiral analysis in early Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

The effect of estrogen replacement on early Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Estradiol protects dopaminergic neurons in a MPP+Parkinson's disease model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Viral vector-mediated overexpression of estrogen receptor-alpha in striatum enhances the estradiol-induced motor activity in female rats and estradiol-modulated GABA release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Long-term administration of estrogen or tamoxifen to ovariectomized rats affords neuroprotection to hippocampal neurons by modulating the expression of Bcl-2 and Bax.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Chronic exposure to estrogen and tamoxifen regulates synaptophysin and phosphorylated cAMP response element-binding (CREB) protein expression in CA1 of ovariectomized rat hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ERalpha and ERbeta).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Role of nonfeminizing estrogens in brain protection from cerebral ischemia: an animal model of Alzheimer's disease neuropathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Molecular biology, pharmacology and functional role of the plasma membrane dopamine transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Update in hormone therapy use in menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Coping with menstruation: understanding the needs of women with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Systematic review of incidence studies of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

17β-estradiol protects dopaminergic neurons in organotypic slice of mesencephalon by MAPK-mediated activation of anti-apoptosis gene BCL2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Are men at greater risk for Parkinson's disease than women?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Association between AKT1 gene and Parkinson's disease: a protective haplotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

The assessment of non-feminizing estrogens for use in neuroprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Role of Dickkopf-1, an antagonist of the Wnt/beta-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Design, synthesis, and estrogenic activity of a novel estrogen receptor modulator--a hybrid structure of 17beta-estradiol and vitamin E in hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

Effects of female sex steroids on Parkinson's disease in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YFRNE.2012.02.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YFRNE.2012.02.003

1 reference

26 August 2017

1 reference